Provided by Tiger Trade Technology Pte. Ltd.

Tango Therapeutics Inc.

23.24
-1.2100-4.95%
Post-market: 23.00-0.2400-1.03%19:44 EDT
Volume:5.25M
Turnover:124.64M
Market Cap:3.93B
PE:-27.67
High:25.09
Open:25.09
Low:23.09
Close:24.45
52wk High:34.39
52wk Low:6.69
Shares:169.00M
Float Shares:120.00M
Volume Ratio:1.72
T/O Rate:4.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8400
EPS(LYR):-0.8746
ROE:-21.34%
ROA:-12.99%
PB:3.83
PE(LYR):-26.57

Loading ...

Tango Therapeutics Q1 FY26 net loss widens to $45.51 million

Reuters
·
May 14

Tango Therapeutics Q1 EPS USD -0.32

THOMSON REUTERS
·
May 14

Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights

GlobeNewswire
·
May 14

Tango Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
May 09

Tango Therapeutics Inc - Daniella Beckman to Step Down as CFO Effective April 15, 2026 - SEC Filing

THOMSON REUTERS
·
May 08

Tango Therapeutics CFO Daniella Beckman steps down effective April 15

Reuters
·
May 08

Tango Therapeutics President R&D Crystal Adam sells USD 572,610 common shares

Reuters
·
May 06

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 05

How New C-Suite Hires At Tango Therapeutics (TNGX) Have Changed Its Investment Story

Simply Wall St.
·
Apr 29

Tango Therapeutics Inc : Stifel Raises Target Price to $40 From $24

THOMSON REUTERS
·
Apr 27

Tango Therapeutics CFO Matthew Gall files initial beneficial ownership statement

Reuters
·
Apr 25

Tango Therapeutics announces annual shareholder meeting

Reuters
·
Apr 17

Tango Therapeutics President R&D Crystal Adam sells 38,460 shares for $961,500

Reuters
·
Apr 17

BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems

Reuters
·
Apr 16

Tango Therapeutics names Matthew Gall CFO, replacing Daniella Beckman

Reuters
·
Apr 15

Tango Therapeutics Inc - Appoints Matthew Gall as CFO Effective April 15 Succeeding Daniella Beckman

THOMSON REUTERS
·
Apr 15

Press Release: Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat

Dow Jones
·
Apr 15

Tango Therapeutics President, R&D Crystal Adam disposes $0.6 million common shares

Reuters
·
Apr 03

Tango Therapeutics initiated with a Buy at Canaccord

TIPRANKS
·
Apr 02